Postbaseline bone marrow blast reduction. Maximum posttreatment percentage change in marrow blasts (relative to baseline); patients who achieved remission are denoted. 10+Aza = 10 µg/kg vadastuximab talirine plus azacitidine, 10+Dec = 10 µg/kg vadastuximab talirine plus decitabine.